From: Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results
Study
N
Treatment Arms
mOS (months)
2y OS
FFCD-SFRO [5]
119
60Gy/30 fractions + 5Fu + cis- > gem
8.6
~ 15%a
gem
13, p = 0.03
~ 21%a
ECOG 4201 [8]
74
50.4Gy/28 fractions - > gem
11.1
12%
9.2, p = 0.017
5%
LAP-07 [7]
269b
gem+/−erlotinib ->
54Gy + cape
15.2
~ 25%a
16.5, NS